Story Brooke 4

What Happened
Story Brooke, a director of PolyPid Ltd. (PYPD), was granted a derivative equity award on July 15, 2026: 9,132 option-type shares shown at $4.46 per share for a total reported value of $40,729. This is an award/acquisition (not an open-market purchase or sale) tied to future vesting rather than an immediate stock purchase.

Key Details

• Transaction date: July 15, 2026 (reported on Form 4 filed July 17, 2026) — filing appears timely.
• Grant: 9,132 derivative shares at $4.46 per share; total reported value $40,729.
• Vesting: Footnote indicates these are options that vest quarterly beginning July 15, 2026 and continuing through April 15, 2030.
• Shares owned after transaction: Not specified in the supplied filing details.
• Transaction code: A (award/grant); derivative security (options). No 10b5-1 plan, tax-withholding, or late filing noted in the provided information.

Context: This was a standard equity-compensation option grant that vests over time. Because these are options, they must vest and then be exercised to become shares; the award itself does not represent an immediate open-market purchase or sale. For retail investors, such grants are common as part of director compensation and should be interpreted as compensation-related acquisitions rather than direct market bets by the insider.